W.T. Kuo, Y.C. Lee, J.B. Liao, C.J. Tseng, Y.F. Yang*, Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma. Discov Oncol, 16 (2025) 126.
Y.H. Lin, Y.C. Lee, J.B. Liao, P.L. Yu, C.Y. Chou, Y.F. Yang*, Alda-1 restores ALDH2-mediated alcohol metabolism to inhibit the NF-kappaB/VEGFC axis in head and neck cancer. Int J Mol Med, 55 (2025).
Y.F. Yang, S.H. Yu, J.B. Liao, Y.H. Lin, Identification and validation of Novel Estrogen Biosynthesis Biomarkers in Sinonasal Inverted Papilloma. Int J Med Sci, 22 (2025) 158-169.
M.H. Lin, Y.C. Lee, J.B. Liao, C.Y. Chou, Y.F. Yang*, PTGES is involved in myofibroblast differentiation via HIF-1alpha-dependent glycolysis pathway. J Cell Mol Med, 28 (2024) e70157.
W.T. Kuo, Y.C. Lee, Y.F. Yang, C.F. Cheng, C.J. Tseng, K.W. Tsai, Sushi Domain Containing 2 Dysfunction Contributes to Cancer Progression in Patients with Bladder Cancer. J Cancer, 15 (2024) 5318-5328.
W.C. Hu#, Y.F. Yang#, C.F. Cheng, Y.T. Tu, H.T. Chang, K.W. Tsai, Overexpression of malic enzyme is involved in breast cancer growth and is correlated with poor prognosis. J Cell Mol Med, 28 (2024) e18163.
H.W. Chuang, L.H. Lin, D.D. Ji, T.Y. Fu, H.S. Lee, Y.F. Yang, H.C. Tseng, K.T. Hsia, Serpin peptidase inhibitor, clade E, member 2 is associated with malignant progression and clinical prognosis in oral squamous cell carcinoma. J Dent Sci, 19 (2024) 70-78.
K.W. Tsai, Y.F. Yang, L.J. Wang, C.C. Pan, C.H. Chang, Y.C. Chiang, T.Y. Wang, R.B. Lu, S.Y. Lee, Correlation of potential diagnostic biomarkers (circulating miRNA and protein) of bipolar II disorder. J Psychiatr Res, 172 (2024) 254-260.
[1] Y.F. Yang, S.H. Yu, J.B. Liao, Y.H. Lin, Identification and validation of Novel Estrogen Biosynthesis Biomarkers in Sinonasal Inverted Papilloma. Int J Med Sci, 22 (2025) 158-169.
A. Vadhan, Y.F. Yang, Y.M. Wang, P.Y. Chen, S.C. Tzou, K.H. Cheng, S.C. Hu, T.L. Cheng, Y.Y. Wang, S.F. Yuan, Fumarate hydratase inhibits non-small cell lung cancer metastasis via inactivation of AMPK and upregulation of DAB2. Oncol Lett, 25 (2023) 42.
C.Y. Tsai, J.B. Liao, Y.C. Lee, Y.F. Yang*, HOXC8 mediates osteopontin expression in gastric cancer cells. J Cancer, 14 (2023) 2552-2561.
Y.H. Lin, Y.F. Yang, J.B. Liao, T.S. Chang, U.G.S. Janesha, Y.L. Shiue, Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma. J Cancer, 14 (2023) 1689-1706.
Y.C. Chang, M.H. Chan, Y.F. Yang, C.H. Li, M. Hsiao, Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression. Cancer letters, 563 (2023) 216179.
Y.F. Yang, C.H. Li, H.Y. Cai, B.S. Lin, C.H. Kim, Y.C. Chang, Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis. Int J Mol Sci, 23 (2022).
Y.F. Yang, Y.C. Chang, K.W. Tsai, M.H. Hung, B.H. Kang, UBE2C triggers HIF-1alpha-glycolytic flux in head and neck squamous cell carcinoma. J Cell Mol Med, (2022).
Y.H. Lin, Y.F. Yang, Y.L. Shiue, Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma. Diagnostics (Basel), 12 (2022).
Y.C. Lee, K.W. Tsai, J.B. Liao, W.T. Kuo, Y.C. Chang, Y.F. Yang, High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging. Sci Rep, 12 (2022) 1496.
Y.F. Yang, H.W. Chuang, W.T. Kuo, B.S. Lin, Y.C. Chang, Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer. Int J Mol Sci, 22 (2021).
C.H. Li, Y.C. Chang, M.H. Chan, Y.F. Yang, S.M. Liang, M. Hsiao, Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives. Biomedicines, 9 (2021).
H.W. Chuang, K.T. Hsia, J.B. Liao, C.C. Yeh, W.T. Kuo, Y.F. Yang, SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma. Diagnostics (Basel), 11 (2021).
J.R. Chen, M.S. Huang, Y.C. Lee, M.H. Lin, Y.F. Yang, Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer. J Oncol, 2021 (2021) 1901191.
Y.F. Yang, Y.Y. Wang, M. Hsiao, S. Lo, Y.C. Chang, Y.H. Jan, T.C. Lai, Y.C. Lee, Y.C. Hsieh, S.F. Yuan, IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway. Cancer letters, 485 (2020) 27-37.
Y.F. Yang, Y.C. Chang, Y.H. Jan, C.J. Yang, M.S. Huang, M. Hsiao, Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway. Oncogenesis, 9 (2020) 78.
J.H. Wang, T.J. Lu, M.L. Kung, Y.F. Yang, C.Y. Yeh, Y.T. Tu, W.S. Chen, K.W. Tsai, The Long Noncoding RNA LOC441461 (STX17-AS1) Modulates Colorectal Cancer Cell Growth and Motility. Cancers (Basel), 12 (2020).
T.C. Lai, C.Y. Fang, Y.H. Jan, H.L. Hsieh, Y.F. Yang, C.Y. Liu, P.M. Chang, M. Hsiao, Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-kappaB signaling pathway. Cell Commun Signal, 18 (2020) 164.
Y.C. Chang#, Y.F. Yang#, J. Chiou, H.F. Tsai, C.Y. Fang, C.J. Yang, C.L. Chen, M. Hsiao, Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness. Cell Death Dis, 11 (2020) 195.
Y.F. Yang, Y.C. Lee, Y.Y. Wang, C.H. Wang, M.F. Hou, S.F. Yuan, YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells. Kaohsiung J Med Sci, (2019).
Y.C. Chang, J. Chiou, Y.F. Yang, C.Y. Su, Y.F. Lin, C.N. Yang, P.J. Lu, M.S. Huang, C.J. Yang, M. Hsiao, Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival. Cancer research, (2019).
Y.F. Yang, Y.C. Lee, S. Lo, Y.N. Chung, Y.C. Hsieh, W.C. Chiu, S.F. Yuan, A positive feedback loop of IL-17B-IL-17RB activates ERK/beta-catenin to promote lung cancer metastasis. Cancer letters, 422 (2018) 44-55.
C.H. Wang, P.J. Wang, Y.C. Hsieh, S. Lo, Y.C. Lee, Y.C. Chen, C.H. Tsai, W.C. Chiu, S. Chu-Sung Hu, C.W. Lu, Y.F. Yang, C.C. Chiu, F. Ou-Yang, Y.M. Wang, M.F. Hou, S.S. Yuan, Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties. Oncogene, 37 (2018) 589-600.
C.W. Lu, Y.H. Lo, C.H. Chen, C.Y. Lin, C.H. Tsai, P.J. Chen, Y.F. Yang, C.H. Wang, C.H. Tan, M.F. Hou, S.F. Yuan, VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis. Cancer letters, 388 (2017) 130-138.
P.C. Lin#, Y.F. Yang#, Y.C. Tyan, E.S. Hsiao, P.C. Chu, C.T. Lee, J.C. Lee, Y.M. Chen, P.C. Liao, Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses. PloS one, 11 (2016) e0158844.
H.Y. Wu, Y.G. Goan, Y.H. Chang, Y.F. Yang, H.J. Chang, P.N. Cheng, C.C. Wu, V.G. Zgoda, Y.J. Chen, P.C. Liao, Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry. Journal of proteome research, 14 (2015) 3039-3050.
J.S. Chang, C.Y. Su, W.H. Yu, W.J. Lee, Y.P. Liu, T.C. Lai, Y.H. Jan, Y.F. Yang, C.N. Shen, J.Y. Shew, J. Lu, C.J. Yang, M.S. Huang, P.J. Lu, Y.F. Lin, M.L. Kuo, K.T. Hua, M. Hsiao, GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis. Oncotarget, 6 (2015) 36278-36291.
Y.F. Yang#, Y.H. Jan#, Y.P. Liu, C.J. Yang, C.Y. Su, Y.C. Chang, T.C. Lai, J. Chiou, H.Y. Tsai, J. Lu, C.N. Shen, J.Y. Shew, P.J. Lu, Y.F. Lin, M.S. Huang, M. Hsiao, Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis. American journal of respiratory and critical care medicine, 190 (2014) 675-687.
H.Y. Tsai#, Y.F. Yang#, A.T. Wu, C.J. Yang, Y.P. Liu, Y.H. Jan, C.H. Lee, Y.W. Hsiao, C.T. Yeh, C.N. Shen, P.J. Lu, M.S. Huang, M. Hsiao, Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78. Oncogene, 32 (2013) 4921-4931.
Y.H. Jan, H.Y. Tsai, C.J. Yang, M.S. Huang, Y.F. Yang, T.C. Lai, C.H. Lee, Y.M. Jeng, C.Y. Huang, J.L. Su, Y.J. Chuang, M. Hsiao, Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3. Cancer research, 72 (2012) 5119-5129.